About Recordati
Recordati is a company based in Milan (Italy) founded in 1926 was acquired by CVC in July 2017. Recordati has completed 6 acquisitions, including EUSA Pharma, Italchimici and Laboratorios Casen Fleet. Recordati offers products and services including Specialty and Primary Care Medicines, Rare Diseases Medicines, and Chemical Products.
- Headquarter Milan, Italy
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Opalia S.R.O.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Investments & Acquisitions
EUSA Pharma
& 5 more
-
Acquired by
CVC
(Jul 01, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Recordati
Recordati offers a comprehensive portfolio of products and services, including Specialty and Primary Care Medicines, Rare Diseases Medicines, and Chemical Products.
Medicines for common diseases and primary care treatments.
Treatments targeting rare medical conditions globally.
Industrial chemicals used in pharmaceutical manufacturing.
People of Recordati
Unlock access to complete
Leadership Team
3 people
General Team
1 people
National Team
1 people
MSAT Team
1 people
Key Team
1 people
Unlock access to complete
Funding Insights of Recordati
Detailed funding history for Recordati
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Recordati
Recordati has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include CVC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Mezzanine financing and equity investments are provided by CVC.
|
Locked | Locked | Locked |
Investor details for Recordati
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Recordati
Recordati has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include EUSA Pharma, Italchimici and Laboratorios Casen Fleet.
Investment portfolio details for Recordati
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Pharmaceuticals for diseases including gastroenterology and women's health are developed.
|
Locked | Locked | 2022 | Locked | |
|
Manufacturer of all-terrain pushchairs and electric cargo bikes
|
Locked | Locked | 2015 | Locked | |
|
Developer and commercializer of pharmaceutical medicines
|
Locked | Locked | 2006 | Locked |
Complete acquisition details for Recordati
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Recordati
Detailed financials for Recordati
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Recordati Comparisons
Peer comparison for Recordati
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Recordati
Detailed competitors of Recordati
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Recordati
Complete news archive for Recordati
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Recordati
Recordati was founded in 1926.
Recordati is headquartered in Milan, Italy. It is registered at Milan, Lombardy, Italy.
Recordati was founded in 1926 in Milan, Italy, as a company in the pharmaceutical sector. Research, development, manufacturing, and marketing of pharmaceuticals and pharmaceutical chemicals are conducted. Two active pharmaceutical ingredient manufacturing sites are maintained. Lead candidates include REC 0551, in phase 2 for retinopathy of prematurity, and LYNOVEX, in phase 2 for acute infectious exacerbations in cystic fibrosis. REAGILA has been introduced for schizophrenia treatment.
Recordati offers Specialty and Primary Care Medicines, Rare Diseases Medicines, and Chemical Products.
Recordati has made 6 acquisitions, including EUSA Pharma, Italchimici, and Laboratorios Casen Fleet.
Recordati has 1 investor. Key investors include CVC.